See LEGEND for key to shading and symbols.
Subject Area - MFAC Term - Term 2 2020
Data is correct as at Sun 27 Sep 20:50:36 AEST 2020
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
MFAC1523 | Health Maintenance A (M2A) | ||||||
CRS | CR01 | 2863 | Open | 0/63 | 0% | (Course Enrolment, UGRD) | |
OTH | KEN | 10504 | Enr | Open | 489/550 | 89% | |
OTH | PORT | 10505 | Enr | Full | 50/50 | 100% | |
MFAC1601 | Intro Clinical and Com Skills (M2A) | ||||||
CRS | CR01 | 2886 | Open | 0/4 | 0% | (Course Enrolment, UGRD) | |
TUT | KEN | 3713 | Enr | Open | 11/15 | 73% | |
MFAC2505 | Integrated Clinical Studies A (MT2) | ||||||
CRS | CR01 | 2864 | Open | 0/1 | 0% | (Course Enrolment, UGRD) | |
MFAC2506 | Integrated Clinical Studies B (MT2) | ||||||
CRS | CR01 | 2854 | Open | 0/1 | 0% | (Course Enrolment, UGRD) | |
MFAC2509 | Clinical Skills Refresher (MT2) | ||||||
CRS | CR01 | 2911 | Open | 0/-2 | N/A | (Course Enrolment, UGRD) | |
CLN | SYD | 3677 | Enr | Full | 7/5 | 100% | |
MFAC2515 | Integrated Clinical Studies 2 (MT2) | ||||||
CRS | CR01 | 2807 | Open | 0/33 | 0% | (Course Enrolment, UGRD) | |
OTH | KEN | 3711 | Enr | Open | 232/250 | 93% | |
OTH | RCS | 3712 | Enr | Open | 52/60 | 87% | |
MFAC2521 | ICS A (Spec.Prog.) (MT2) | ||||||
CRS | CR01 | 2539 | Open | 0/1 | 0% | (Course Enrolment, UGRD) | |
MFAC2522 | ICS B (Spec.Prog.) (MT2) | ||||||
CRS | CR01 | 2623 | Open | 0/1 | 0% | (Course Enrolment, UGRD) | |
MFAC2523 | ICS A (Spec.Prog.) (MT2) | ||||||
CRS | CR01 | 2618 | Open | 0/1 | 0% | (Course Enrolment, UGRD) | |
MFAC2524 | ICS B (Spec.Prog.) (MT2) | ||||||
CRS | CR01 | 2538 | Open | 0/1 | 0% | (Course Enrolment, UGRD) | |
MFAC2525 | ICS A (Spec.Prog.) (MT2) | ||||||
CRS | CR01 | 2528 | Open | 0/1 | 0% | (Course Enrolment, UGRD) | |
MFAC2526 | ICS B (Spec.Prog.) (MT2) | ||||||
CRS | CR01 | 2346 | Open | 0/1 | 0% | (Course Enrolment, UGRD) | |
MFAC2527 | ICS A (Spec.Prog.) (MT2) | ||||||
CRS | CR01 | 2575 | Open | 0/1 | 0% | (Course Enrolment, UGRD) | |
MFAC2528 | ICS B (Spec.Prog.) (MT2) | ||||||
CRS | CR01 | 2527 | Open | 0/1 | 0% | (Course Enrolment, UGRD) | |
MFAC3501 | Medicine (M2A) | ||||||
CRS | CR01 | 2896 | Open | 0/55 | 0% | (Course Enrolment, UGRD) | |
CLN | RCS3 | 3657 | Enr | Open | 5/30 | 17% | |
CLN | SYD3 | 3654 | Enr | Open | 51/80 | 64% | |
MFAC3502 | Surgery (M2A) | ||||||
CRS | CR01 | 2900 | Open | 0/59 | 0% | (Course Enrolment, UGRD) | |
CLN | RCS3 | 3655 | Enr | Open | 14/30 | 47% | |
CLN | SYD3 | 3656 | Enr | Open | 37/80 | 46% | |
MFAC3503 | Psychiatry (M2A) | ||||||
CRS | CR01 | 2901 | Open | 0/20 | 0% | (Course Enrolment, UGRD) | |
CLN | RCS3 | 3659 | Enr | Open | 20/30 | 67% | |
CLN | SYD3 | 3658 | Enr | Open | 50/60 | 83% | |
MFAC3504 | Primary Care (M2A) | ||||||
CRS | CR01 | 2899 | Open | 0/18 | 0% | (Course Enrolment, UGRD) | |
CLN | RCS3 | 3661 | Enr | Open | 16/30 | 53% | |
CLN | SYD3 | 3660 | Enr | Open | 56/60 | 93% | |
MFAC3505 | Obstetrics & Gynaecology (M2A) | ||||||
CRS | CR01 | 2902 | Open | 0/50 | 0% | (Course Enrolment, UGRD) | |
CLN | RCS3 | 3663 | Enr | Open | 13/30 | 43% | |
CLN | SYD3 | 3662 | Enr | Open | 27/60 | 45% | |
MFAC3506 | Children's Health (Paeds) (M2A) | ||||||
CRS | CR01 | 2895 | Open | 0/44 | 0% | (Course Enrolment, UGRD) | |
CLN | RCS3 | 3665 | Enr | Open | 16/30 | 53% | |
CLN | SYD3 | 3664 | Enr | Open | 31/60 | 52% | |
MFAC3508 | Emergency/Selective (M2A) | ||||||
CRS | CR01 | 2906 | Open | 0/76 | 0% | (Course Enrolment, UGRD) | |
CLN | RCS3 | 3667 | Enr | Open | 4/30 | 13% | |
CLN | SYD3 | 3666 | Enr | Open | 50/100 | 50% | |
MFAC3509 | Selective (M2A) | ||||||
CRS | CR01 | 2905 | Open | 0/103 | 0% | (Course Enrolment, UGRD) | |
CLN | RCS3 | 3669 | Enr | Open | 60/72 | 83% | |
CLN | SYD3 | 3668 | Enr | Open | 109/200 | 55% | |
MFAC3512 | Phase 3 Biomed Sci Viva (M2A) | ||||||
CRS | CR01 | 2912 | Open | 0/2 | 0% | (Course Enrolment, UGRD) | |
MFAC3514 | Elective (M2A) | ||||||
CRS | CR01 | 2883 | Open | 0/2 | 0% | (Course Enrolment, UGRD) | |
CLN | SYD2 | 3714 | Enr | Open | 0/2 | 0% | |
MFAC3515 | PRINT (M2A) | ||||||
CRS | CR01 | 2884 | Open | 0/2 | 0% | (Course Enrolment, UGRD) | |
MFAC3522 | Phase 3 Portfolio Examination (M2A) | ||||||
CRS | CR01 | 2721 | Open | 0/2 | 0% | (Course Enrolment, UGRD) | |
MFAC3523 | Phase 3 Integrated Clinical Ex (M2A) | ||||||
CRS | CR01 | 2678 | Open | 0/2 | 0% | (Course Enrolment, UGRD) | |
MFAC4521 | Independent Learning Project 1 (MT2) | ||||||
CRS | CR01 | 2641 | Open | 0/300 | 0% | (Course Enrolment, UGRD) | |
MFAC4522 | Independent Learning Project 2 (MT2) | ||||||
CRS | CR01 | 2170 | Open | 0/144 | 0% | (Course Enrolment, UGRD) | |
OTH | ALBY | 10527 | Enr | Open | 4/30 | 13% | |
OTH | COFF | 10528 | Enr | Open | 8/30 | 27% | |
OTH | KENS | 10526 | Enr | Open | 197/250 | 79% | |
OTH | PORT | 10529 | Enr | Open | 11/30 | 37% | |
OTH | WGGA | 10530 | Enr | Open | 6/30 | 20% | |
MFAC4523 | Independent Learning Project 3 (MT2) | ||||||
CRS | CR01 | 2066 | Open | 0/300 | 0% | (Course Enrolment, UGRD) | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australia Telephone: (within Aust.) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G ABN: 57 195 873 179 Authorised by Vice-President and Deputy Vice-Chancellor (Academic) Privacy Policy Copyright & Disclaimer Accessibility |